Why dual signalling matters: GLP-1 provides powerful appetite and glucose-regulation effects, while GIP adds a complementary incretin signal
Patients discontinuing GLP-1 medications should monitor for signs of gallbladder problems (severe abdominal pain, especially after meals), pancreatitis (persistent severe abdominal pain, sometimes with vomiting), or significant hyperglycemia
Furthermore, adaptor proteins and neurotrophic factor receptors located downstream of leptin and MC4R signaling are also critical
Daily SPF application helps preserve your results and prevents new damage from forming, ensuring your investment continues to pay off
Ready to explore if GLP1 medications could be right for you
The timing of administration may vary depending on individual treatment plans and medical recommendations